These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 30612698)
21. New frontiers of therapy in hemato-oncology. Mukherjee N J Assoc Physicians India; 2002 Jul; 50():950-61. PubMed ID: 12126354 [No Abstract] [Full Text] [Related]
22. [Targeted therapy in the treatment of solid tumors and in hematology-oncology. Advances and disappointments]. Jochims C; Mazitschek U; Jäger D; Goldschmidt H Internist (Berl); 2006 Jun; 47(6):633-41. PubMed ID: 16767478 [TBL] [Abstract][Full Text] [Related]
23. [Advances in medical oncology]. Shi YK Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):305-10. PubMed ID: 16900620 [TBL] [Abstract][Full Text] [Related]
24. Targeted and tailored therapy in hemato-oncology: vision for the 21st century. Shpilberg O; Ben-Bassat I; Raanani P Isr Med Assoc J; 2006 Dec; 8(12):843-4. PubMed ID: 17214100 [TBL] [Abstract][Full Text] [Related]
25. Customer pyramid framework for CAR T-cell therapies in immuno-oncology. Malik NN; Durdy MB Drug Discov Today; 2016 Oct; 21(10):1563-1565. PubMed ID: 27640934 [No Abstract] [Full Text] [Related]
26. Immuno-Oncology in China. Lu S; Chabner BA Oncologist; 2019 Feb; 24(Suppl 1):S1-S2. PubMed ID: 30819825 [TBL] [Abstract][Full Text] [Related]